Integrated Pharmacy 1 Drug Discovery Exam 2026 – Complete Practice Test

Phase II trials are designed to see if the drug has real therapeutic effect in patients with the target condition while continuing to monitor safety in a larger, more relevant population. They also help identify the appropriate dose and assess how tolerable the regimen is in practice. Because of this, the primary aim includes both safety and efficacy, with an eye toward feasibility and tolerability of the treatment plan.

Pharmacokinetics, while sometimes measured, is not the main goal of Phase II. That aspect is more central to Phase I (and early pharmacology studies). The option that combines safety, efficacy, and feasibility/tolerability best reflects Phase II's purpose.